Treatment of Heart Failure With Preserved Ejection Fraction
Key result
Aldosterone antagonist therapy for heart failure with preserved ejection fraction is reviewed to highlight clinical management lessons from the TOPCAT trial.
Population
Patients with heart failure with preserved ejection fraction (HFpEF)
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
This Viewpoint discusses the management of HFpEF and lessons learned from the TOPCAT trial.
Structured PICO
P
Population
Patients with heart failure with preserved ejection fraction (HFpEF)
I
Intervention
Aldosterone Antagonist (discussion based on the TOPCAT trial)
This Viewpoint discusses the management of HFpEF and lessons learned from the TOPCAT trial.
Cite This Study
Pfeffer et al. (2016) studied this question. Aldosterone antagonist therapy for heart failure with preserved ejection fraction is reviewed to highlight clinical management lessons from the TOPCAT trial.